{
  "docId": "019dd923-5de0-76bd-a164-b717ba6950ff",
  "docSlug": "eb4f894ec6f4abbf",
  "documentTitle": "Medical Affairs Outlook Report 2023",
  "authorId": "ZS",
  "authorName": "ZS",
  "documentKindSlug": "consulting-deck",
  "documentKindLabel": "Consulting deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "portrait",
  "aspectRatio": 0.773,
  "pageNumber": 13,
  "pageCount": 17,
  "prevPage": 12,
  "nextPage": 14,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide is a text-heavy report page summarizing findings from external and internal respondents.",
  "elementsJson": [
    "paragraph"
  ],
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5de0-76bd-a164-b717ba6950ff/13",
  "deckHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff",
  "deckJsonHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff.json",
  "deckAnchorHref": "/decks/019dd923-5de0-76bd-a164-b717ba6950ff#slide-13",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "As virtual engagements still constitute about 40% of MSL-KOL interactions, it's crucial for pharma organizations to understand KOL preferences and identify the most effective tools and technologies for reaching them.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd951-edaa-73b9-902a-9d425f80a75d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.58,
        "x": 0.21,
        "y": 0.78
      },
      "kind": "paragraph",
      "text": "With the common goal of delivering value to patients, pharma companies and KOLs are undertaking multiple initiatives to improve the patient experience.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "47a61bdb-2ebe-4c6d-a722-9dd153f866f5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.58,
        "x": 0.21,
        "y": 0.34
      },
      "kind": "paragraph",
      "text": "As virtual engagements still constitute about 40% of MSL-KOL interactions, it's crucial for pharma organizations to understand KOL preferences and identify the most effective tools and technologies for reaching them.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b771341d-0876-42ec-a6ad-fe998971b79f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.58,
        "x": 0.21,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "As pharma adopts digital technologies and virtual interactions, decentralized clinical trials (DCTs) are emerging as an important approach to improve trial recruitment and patient centricity.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc2212bb-04e5-4774-b674-630bf941699a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.18,
        "x": 0.21,
        "y": 0.75
      },
      "kind": "title",
      "text": "Patient centricity",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9bb2b4e8-af97-4cda-8276-20a1f5ec91ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.21,
        "y": 0.31
      },
      "kind": "title",
      "text": "Digital and social media",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fbf520bd-4e40-4889-8ba7-468ceace1adf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 15,
      "from": 9,
      "beatId": "c525a5ef-3a99-4c51-8abc-eb5dad661dff",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Solution & Approach",
      "beatSlug": "consultants-gambit-solution-approach",
      "evidence": "The deck provides key takeaways and recommendations for medical affairs organizations, including prioritizing investments and collaborating with external stakeholders",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    },
    {
      "to": 14,
      "from": 10,
      "beatId": "ddd73dd8-76c8-4866-b638-a1b59773307b",
      "arcName": "The Consultant's Gambit",
      "arcSlug": "consultants-gambit",
      "beatName": "Evidence & Proof",
      "beatSlug": "consultants-gambit-evidence-proof",
      "evidence": "The deck provides data and statistics to support its recommendations, including survey results from internal and external respondents",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 15,
      "from": 6,
      "name": "Logic Chain",
      "slug": "01-logic-chain",
      "bestFor": "Skeptical audiences, controversial recommendations, rigorous analysis",
      "matchId": "fb6f3987-81f5-48cc-b7d0-39a0cd21772e",
      "evidence": "The deck presents a logical chain of ideas, starting with the situation overview and building towards key takeaways and recommendations",
      "position": 0,
      "objective": "Understand the engagement landscape and prioritize investments",
      "structure": "Premise 1 (Accepted truth) -> Premise 2 (Observed fact) -> Therefore... (Inevitable conclusion)",
      "confidence": 0.7,
      "description": "Build an airtight chain of logic where each premise leads inevitably to the conclusion"
    },
    {
      "to": 15,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "dff223a3-dda3-48f8-a5dd-27a7371e6fe5",
      "evidence": "The deck implies that not prioritizing investments and adapting to changing engagement landscapes may result in missed opportunities",
      "position": 1,
      "objective": "Highlight the consequences of not adapting to changing engagement landscapes",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}